Peptides vs. steroids: what TikTok gets dangerously wrong

What's this video probably claiming?

Based on the caption, hashtag, and the fact that this creator's content falls under peptide therapy, this video is almost certainly pitching peptides, specifically compounds like BPC-157, TB-500, or growth hormone secretagogues like ipamorelin, as a smarter or safer alternative to anabolic steroids. The "don't be a b*tch" framing is a recognizable rhetorical move in fitness content: it dismisses caution as weakness and positions the viewer as needing to "level up" their approach. The implicit argument is probably something like, steroids are old news and risky, peptides give you the gains (or recovery, or body composition changes) without the baggage. That framing is compelling. It is also, in important ways, misleading.

What does the science actually show?

Peptides and anabolic androgenic steroids are genuinely different classes of compounds with different mechanisms, risk profiles, and evidence bases. Anabolic steroids are well-studied, with documented effects and well-documented harms: suppression of endogenous testosterone, cardiovascular remodeling, hepatotoxicity with oral 17-alpha alkylated compounds, and psychiatric effects (Pope et al., 2014, JAMA Psychiatry). The evidence for most peptides being sold online is far thinner. BPC-157 has shown tissue repair and anti-inflammatory effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but human randomized controlled trial data essentially does not exist yet. TB-500 (thymosin beta-4) has a handful of small clinical trials in cardiac repair contexts, not general fitness. MK-677, an oral growth hormone secretagogue, has shown increases in IGF-1 in short-term human trials (Murphy et al., 1998, Journal of Clinical Endocrinology and Metabolism), but also increased fasting glucose and insulin resistance, which rarely makes the TikTok version.

Where does the social media noise diverge from clinical reality?

The biggest divergence is the implied equivalence: that swapping steroids for peptides is simply trading a blunt instrument for a precise one, with the same outcomes but fewer risks. That comparison does not hold up. Anabolic steroids produce well-documented, measurable increases in lean mass and strength, even if the cost is real. Most peptides in the fitness context have either no human efficacy data (BPC-157, TB-500 for muscle building), mixed or context-specific data (ipamorelin, CJC-1295 combinations show modest GH pulse amplification but not bodybuilder-level anabolism), or risks that are poorly characterized because long-term human safety studies do not exist. The other divergence is regulatory reality. The FDA has not approved most of these compounds for general use. Compounded peptides vary in purity and concentration. A 2021 FDA analysis flagged contamination and dosing inconsistencies in multiple compounded peptide products. Telling people to stop being timid about trying unregulated compounds with thin human evidence is not the same as encouraging boldness.

What should you actually know?

If you are considering peptide therapy, the conversation starts with a clinician and your actual health goals, not a TikTok caption designed to provoke a reaction. Some peptide protocols have legitimate emerging evidence and are available through regulated telehealth when prescribed appropriately. Others are essentially being experimented on in humans in real time, with no IRB oversight and no long-term follow-up. The overlap between "fitness peptides" content and actual clinical peptide therapy is smaller than social media makes it look. MK-677, for example, is not a regulated pharmaceutical in the US; it is a research compound frequently sold in gray markets with no manufacturing oversight. Ipamorelin and CJC-1295 combinations require careful monitoring for IGF-1 levels and blood glucose. Anyone presenting peptides as a simple, risk-free upgrade from steroids is skipping over the parts that matter most.